(R)-3-(hydroxymethyl)-5-(2-(5-(hydroxymethyl)-2-isopropoxyphenylamino)pyrimidin-4-yl)-3-methylindoline-7-carbonitrile

ID: ALA4202865

PubChem CID: 130270954

Max Phase: Preclinical

Molecular Formula: C25H27N5O3

Molecular Weight: 445.52

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)Oc1ccc(CO)cc1Nc1nccc(-c2cc(C#N)c3c(c2)[C@@](C)(CO)CN3)n1

Standard InChI:  InChI=1S/C25H27N5O3/c1-15(2)33-22-5-4-16(12-31)8-21(22)30-24-27-7-6-20(29-24)17-9-18(11-26)23-19(10-17)25(3,14-32)13-28-23/h4-10,15,28,31-32H,12-14H2,1-3H3,(H,27,29,30)/t25-/m1/s1

Standard InChI Key:  RISSKZZAQYAEKW-RUZDIDTESA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   12.5238  -20.5564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8114  -20.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5284  -21.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7685  -21.5354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7673  -22.3627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4820  -22.7756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1985  -22.3623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4838  -23.5983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7676  -24.0099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7670  -24.8342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4819  -25.2476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1988  -24.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1958  -24.0081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4802  -21.1227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1991  -21.5332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4713  -20.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6486  -20.3123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0540  -21.1232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3367  -20.7106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5192  -19.7315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9146  -25.2410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6276  -24.8262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3400  -25.2371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0526  -24.8231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0504  -23.9972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3295  -23.5873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6200  -24.0038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3414  -26.0621    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3240  -22.7624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0564  -26.4734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0355  -22.3451    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7702  -26.0597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0578  -27.2984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  1
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7 15  1  0
 14  4  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6  8  1  0
 14 15  2  0
 15  2  1  0
  2 16  1  0
 16 17  1  0
 17 14  1  0
  4 18  1  0
 18 19  3  0
  1 20  1  0
 12 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 23 28  1  0
 26 29  1  0
 28 30  1  0
 29 31  1  0
 30 32  1  0
 30 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4202865

    ---

Associated Targets(Human)

JJN-3 (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KMS-12-BM (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K14 Tchem Mitogen-activated protein kinase kinase kinase 14 (1412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.52Molecular Weight (Monoisotopic): 445.2114AlogP: 3.71#Rotatable Bonds: 7
Polar Surface Area: 123.32Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.50CX Basic pKa: 2.16CX LogP: 2.88CX LogD: 2.88
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -0.39

References

1. Kargbo RB..  (2017)  New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders.,  (9): [PMID:28947934] [10.1021/acsmedchemlett.7b00330]

Source